Janux Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Janux Therapeutics, Inc. (JANX) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$25.00K.
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $25.00K, a 89.45% decline year-over-year.
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$101.00K.
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $54.00K, a 28.57% increase year-over-year.
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $6.00K, a 95.45% decline from fiscal 2023.
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $132.00K, a 21.10% increase from fiscal 2022.
- Janux Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $109.00K, a 186.84% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$101.00K derived: sum of 3 quarters · filed 2026-08-06 | -$47.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-07 | -$76.00K derived: sum of 2 quarters · filed 2026-05-07 | -$22.00K derived: sum of 3 quarters · filed 2026-05-07 | -$212.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$47.00K derived: sum of 2 quarters · filed 2026-02-26 | -$237.00K derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$136.00K derived: sum of 2 quarters · filed 2026-08-06 | $101.00K 10-Q · filed 2025-11-06 | $65.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $47.00K 10-Q · filed 2026-08-06 | $11.00K derived: sum of 3 quarters · filed 2026-08-06 | $53.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $237.00K 10-Q · filed 2026-05-07 | $201.00K derived: sum of 2 quarters · filed 2026-05-07 | $243.00K derived: sum of 3 quarters · filed 2026-05-07 | $243.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.00K derived: sum of 2 quarters · filed 2026-02-26 | $6.00K derived: sum of 3 quarters · filed 2026-02-26 | $6.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $42.00K derived: sum of 2 quarters · filed 2025-11-06 | $42.00K 10-Q · filed 2025-11-06 | -$256.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | -$298.00K derived: sum of 3 quarters · filed 2026-02-26 | -$328.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | -$298.00K derived: sum of 2 quarters · filed 2026-02-26 | -$328.00K derived: sum of 3 quarters · filed 2026-02-26 | -$263.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$328.00K derived: sum of 2 quarters · filed 2026-02-26 | -$263.00K derived: sum of 3 quarters · filed 2026-02-26 | $132.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $35.00K derived: sum of 2 quarters · filed 2024-11-06 | $430.00K 10-Q · filed 2024-11-06 | -$650.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $460.00K 10-Q · filed 2024-08-07 | -$620.00K derived: sum of 3 quarters · filed 2025-02-27 | $106.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $395.00K 10-Q · filed 2024-05-08 | -$685.00K derived: sum of 2 quarters · filed 2025-02-27 | $41.00K derived: sum of 3 quarters · filed 2025-02-27 | $108.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$354.00K derived: sum of 2 quarters · filed 2025-02-27 | -$287.00K derived: sum of 3 quarters · filed 2025-02-27 | $109.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $726.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $793.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.19M 10-Q · filed 2023-11-07 | $374.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $463.00K 10-Q · filed 2023-08-08 | -$352.00K derived: sum of 3 quarters · filed 2023-08-08 | $501.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $396.00K 10-Q · filed 2023-05-09 | -$419.00K derived: sum of 2 quarters · filed 2023-05-09 | $434.00K derived: sum of 3 quarters · filed 2023-05-09 | $430.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$815.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $38.00K derived: sum of 2 quarters · filed 2023-03-10 | $34.00K derived: sum of 3 quarters · filed 2023-03-10 | $38.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $853.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $849.00K derived: sum of 2 quarters · filed 2022-11-10 | $853.00K 10-Q · filed 2022-11-10 | $854.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $1.00K derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-10 | $5.00K derived: sum of 2 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $147.00K 10-K · filed 2022-03-18 | ||
| 2020-09-30 | $146.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |